,15,16,17,18 Furthermore, through an NMUR1-dependent manner, NMU was found to regulate anti-tumor activity of CD8+ T cells, which are the most powerful effectors in the anticancer immune response and form the backbone of current successful cancer immunotherapies.19 The gene discussed is CD8A; the disease is cancer.